FIRE.TO
Latest Trade
0.29CADChange
-0.01(-1.72%)Volume
8,387,837Today's Range
-
0.3052 Week Range
-
0.60As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 0.29 |
|---|---|
Open | 0.30 |
Volume | 8,387,837 |
3M AVG Volume | 236.88 |
Today's High | 0.30 |
Today's Low | 0.28 |
52 Week High | 0.60 |
52 Week Low | 0.12 |
Shares Out (MIL) | 712.97 |
Market Cap (MIL) | 203.20 |
Forward P/E | 57.00 |
Dividend (Yield %) | -- |
Supreme Cannabis Announces Financial Results For Q2 2021
Supreme Cannabis Prices $20 Million Overnight Marketed Public Offering
Supreme Cannabis Announces Financial Results For Q1 2021
Supreme Cannabis Company Inc, formerly Supreme Pharmaceuticals Inc, is a Canada-based company. The Company is focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company's subsidiary is 8528934 Canada Ltd., doing business as 7 ACRES, a licensed producer of medical cannabis. 8528934 Canada Ltd. cultivates medical cannabis at its approximately seven acres (over 342,000 square feet) hybrid greenhouse (the Hybrid Greenhouse) facility in Kincardine, Ontario.
Industry
Biotechnology & Drugs
Executive Leadership
Michael John La Brier
Independent Chairman of the Board
Beena Goldenberg
President, Chief Executive Officer, Director
Nikhil Handa
Chief Financial Officer
John Griese
Chief Operating Officer
Jeff Adams
Executive Vice President- Business Development
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 4.11 |
Price To Book (MRQ) | 0.79 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 42.64 |
LT Debt To Equity (MRQ) | 39.00 |
Return on Investment (TTM) | -25.88 |
Return on Equity (TTM) | -24.09 |
* SUPREME CANNABIS ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS
* SUPREME CANNABIS ANNOUNCES Q3 2020 FINANCIAL RESULTS Source text for Eikon: Further company coverage:
* SUPREME CANNABIS COMPANY INC - NET REVENUE DECREASED MARGINALLY YEAR-OVER-YEAR FROM $10.0 MILLION IN Q3 2019 TO $9.7 MILLION IN Q3 2020
* SUPREME CANNABIS APPOINTS BEENA GOLDENBERG AS PRESIDENT AND CEO
* SUPREME CANNABIS COMPANY INC - TO ISSUE AND SELL UP TO C$9.8 MILLION OF COMMON SHARES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
* COMPLETES FIRST INTERNATIONAL CANNABIS SHIPMENT FROM CANADA INTO ISRAEL Source text for Eikon: Further company coverage:
* SUPREME CANNABIS ANNOUNCES Q2 2020 FINANCIAL RESULTS AND UPDATED PLAN FOR ACCELERATED REVENUE GROWTH
* SUPREME CANNABIS ANNOUNCES Q2 2020 FINANCIAL RESULTS AND UPDATED PLAN FOR ACCELERATED REVENUE GROWTH
* SUPREME CANNABIS COMPANY INC - CORPORATE POSITIONS DECREASED BY APPROXIMATELY 33% AND OPERATIONAL POSITIONS DECREASED BY APPROXIMATELY 13%
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.